Two researchers from the Gulbenkian Science Institute (IGC), Ricardo Henriques and Jorge Carvalho, together with Zita Carvalho-Santos from the Instituto de Medicina Molecular João Lobo Antunes (iMM), received a Chan Zuckerberg Initiative Grant for Cutting-edge Metabolism Research. The awarded project will investigate the organization of cellular metabolism during oocyte development and promises to elucidate how cellular metabolism affects cellular function in physiological and disease settings.

Find out more here.

 

ITQB NOVA researchers Ana Pina and Mónica Serrano lead two of the six Portuguese projects selected in the Caixa Impulse Health Innovation call, promoted by Fundación ”la Caixa”. The research teams will be receiving a total of €98K to develop biological batteries to power e-skin devices and a cheaper and easier-to-implement alternative to PCR tests, transferring their cutting-edge research from the laboratory to patients. Both projects originated from the 2023 edition of the InnOValley Proof-of-Concept Fund, in partnership with Oeiras Valley.

See more here

 

          

Full Professor José Belo, of the NOVA Medical School, was awarded the Career Award of the Portuguese Society for Stem Cells and Cell Therapy (SPCE-TC) for his decades of commitment to the development of scientific knowledge and the training of researchers in the field of stem cells and embryonic development.  The “SPCE-TC Career Award” was presented during the 13th Annual Meeting of the “ETRS & SPCE-TC Joint Meeting” at the University of Coimbra, October 11-13.

Read more here

 

IBET researchers from the Cell-Based Vaccines Development Lab, António Roldão and Raquel Garcia, participated in the 3rd Annual Meeting of the ADDovenom project in Liverpool, UK. The goal of the EU-funded ADDovenom project is to use the innovative ADDomer© platform to develop a novel snakebite therapy with unprecedented efficacy, safety and affordability against the most prevalent snakes in sub-Saharan Africa. During this year’s event, Raquel Garcia presented iBET’s ongoing efforts to optimize the ADDomer purification strategy. ADDovenom is coordinated by the University of Bristol in collaboration with partners at the University of Liège, the University of Aix-Marseille, the Liverpool School of Tropical Medicine and iBET. The project is expected to be completed in 2024, with the 4th and final annual meeting to be held at iBET.

More information here.

 

Congratulations to the team from the Medical Oncology Service II at IPO Lisboa for being the winner of the “SNS Awards” in the category “Humanization of Care”, announced at a ceremony held at the Palácio da Bolsa in Porto, as part of the 44th anniversary of the SNS. The “SNS Awards” aim to recognize, encourage, and inspire excellence in the National Health Service. More than 11,000 health professionals chose the winners in the 17 categories of the “SNS Awards”, made up of a shortlist of finalist projects/teams identified by a Jury of specialists of recognized merit and members of civil society.

Read more here